BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1
205 results:

  • 1. Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous ovarian Carcinoma.
    Wenk D; Khan S; Ignatchenko V; May T; Bernardini MQ; Kislinger T
    J Proteome Res; 2024 Feb; 23(2):749-759. PubMed ID: 38266179
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Peritoneal Fluid Analysis of Advanced ovarian cancers after Hyperthermic Intraperitoneal Chemotherapy.
    Chen WC; Chang TC; Chou HH; Cheng MH; Hong JJ; Hsieh YS; Cheng CM
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298699
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Akt-Activated Endothelium Increases cancer Cell Proliferation and Resistance to Treatment in ovarian cancer Cell Organoids.
    Hoarau-Véchot J; Blot-Dupin M; Pauly L; Touboul C; Rafii S; Rafii A; Pasquier J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430649
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characterization of hci-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line.
    Rush CM; Blanchard Z; Polaski JT; Osborne KS; Osby K; Vahrenkamp JM; Yang CH; Lum DH; Hagan CR; Leslie KK; Pufall MA; Thiel KW; Gertz J
    Sci Rep; 2022 Nov; 12(1):19731. PubMed ID: 36396974
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The protective effect of erythropoietin on ischemia- reperfusion injury caused by ovarian torsion-detorsion in the experimental rat model.
    Kartal B; Bozkurt MF; Alimoğullari E; Saçık U
    J Histotechnol; 2023 Jun; 46(2):57-64. PubMed ID: 36164847
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro.
    Uruski P; Sepetowska A; Konieczna C; Pakuła M; Wyrwa M; Tussupkaliyev A; Tykarski A; Mikuła-Pietrasik J; Książek K
    Cell Mol Biol Lett; 2021 Oct; 26(1):44. PubMed ID: 34674640
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic cancer Early Detection.
    Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
    Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Sitagliptin Modulates the Response of ovarian cancer Cells to Chemotherapeutic Agents.
    Kosowska A; Garczorz W; Kłych-Ratuszny A; Aghdam MRF; Kimsa-Furdzik M; Simka-Lampa K; Francuz T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256016
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. timp-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.
    Escalona RM; Bilandzic M; Western P; Kadife E; Kannourakis G; Findlay JK; Ahmed N
    BMC Cancer; 2020 Oct; 20(1):960. PubMed ID: 33023532
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ERBB2 gene expression silencing involved in ovarian cancer cell migration and invasion through mediating MAPK1/MAPK3 signaling pathway.
    Yu TT; Wang CY; Tong R
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5267-5280. PubMed ID: 32495860
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Circulating Tumor Cells Characterization Revealed timp1 as a Potential Therapeutic Target in ovarian cancer.
    Abreu M; Cabezas-Sainz P; Alonso-Alconada L; Ferreirós A; Mondelo-Macía P; Lago-Lestón RM; Abalo A; Díaz E; Palacios-Zambrano S; Rojo-Sebastian A; López-López R; Sánchez L; Moreno-Bueno G; Muinelo-Romay L
    Cells; 2020 May; 9(5):. PubMed ID: 32423054
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of Matrix Metalloproteinases and Their Inhibitors in Endometrium: High Levels in Endometriotic Lesions.
    Luddi A; Marrocco C; Governini L; Semplici B; Pavone V; Luisi S; Petraglia F; Piomboni P
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325785
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. G Protein-Coupled Receptor 30 Mediates the Anticancer Effects Induced by Eicosapentaenoic Acid in ovarian cancer Cells.
    Zhao Y; Zhao MF; Yang ML; Wu TY; Xu CJ; Wang JM; Li CJ; Li X
    Cancer Res Treat; 2020 Jul; 52(3):815-829. PubMed ID: 32138466
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. timp-1 is Overexpressed and Secreted by Platinum Resistant Epithelial ovarian cancer Cells.
    Sonego M; Poletto E; Pivetta E; Nicoloso MS; Pellicani R; Vinciguerra GLR; Citron F; Sorio R; Mongiat M; Baldassarre G
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861382
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study.
    Khalil C; Moussa M; Azar A; Tawk J; Habbouche J; Salameh R; Ibrahim A; Alaaeddine N
    J Ovarian Res; 2019 Jul; 12(1):70. PubMed ID: 31351482
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Physcion 8-O-β-glucopyranoside exhibits anti-growth and anti-metastatic activities in ovarian cancer by downregulating miR-25.
    Xue CL; Liu HG; Li BY; He SH; Yue QF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5101-5112. PubMed ID: 31298363
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells.
    Rogalska A; Gajek A; Marczak A
    Phytomedicine; 2019 Aug; 61():152847. PubMed ID: 31029905
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells.
    Fecková B; Kimáková P; Ilkovičová L; Szentpéteriová E; Macejová M; Košuth J; Zulli A; Debeljak N; Hudler P; Jašek K; Kašubová I; Kubatka P; Solár P
    BMC Genet; 2019 Jan; 20(1):1. PubMed ID: 30606107
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting cytokines secreted by CD4
    Ke X; Shen L
    Scand J Immunol; 2019 Feb; 89(2):e12736. PubMed ID: 30485902
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of Candidate Genes Associated with Chemotherapy Resistance in ovarian cancer.
    Zhang B; Wang L; Zhao X; Wei Y; Zhang Y
    Ann Clin Lab Sci; 2018 Sep; 48(5):573-579. PubMed ID: 30373860
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.